nodes	percent_of_prediction	percent_of_DWPC	metapath
Procarbazine—Alkylating Activity—Dacarbazine—pancreatic cancer	0.653	1	CiPCiCtD
Procarbazine—CYP1B1—Tamoxifen—pancreatic cancer	0.0768	0.289	CbGbCtD
Procarbazine—CYP1B1—Erlotinib—pancreatic cancer	0.0653	0.245	CbGbCtD
Procarbazine—XDH—Doxorubicin—pancreatic cancer	0.0485	0.182	CbGbCtD
Procarbazine—CYP1B1—Docetaxel—pancreatic cancer	0.0432	0.162	CbGbCtD
Procarbazine—CYP1B1—Doxorubicin—pancreatic cancer	0.0322	0.121	CbGbCtD
Procarbazine—Ibuprofen—CXCL8—pancreatic cancer	0.000539	0.504	CrCbGaD
Procarbazine—Ibuprofen—PPARG—pancreatic cancer	0.000372	0.349	CrCbGaD
Procarbazine—Ibuprofen—PTGS2—pancreatic cancer	0.000157	0.147	CrCbGaD
Procarbazine—Ataxia—Epirubicin—pancreatic cancer	7.02e-05	0.000876	CcSEcCtD
Procarbazine—Vomiting—Erlotinib—pancreatic cancer	7.02e-05	0.000875	CcSEcCtD
Procarbazine—Somnolence—Irinotecan—pancreatic cancer	7e-05	0.000873	CcSEcCtD
Procarbazine—Headache—Tamoxifen—pancreatic cancer	6.99e-05	0.000872	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	6.98e-05	0.000871	CcSEcCtD
Procarbazine—Rash—Erlotinib—pancreatic cancer	6.96e-05	0.000868	CcSEcCtD
Procarbazine—Dermatitis—Erlotinib—pancreatic cancer	6.95e-05	0.000867	CcSEcCtD
Procarbazine—Insomnia—Gemcitabine—pancreatic cancer	6.93e-05	0.000865	CcSEcCtD
Procarbazine—Headache—Erlotinib—pancreatic cancer	6.91e-05	0.000862	CcSEcCtD
Procarbazine—Diplopia—Doxorubicin—pancreatic cancer	6.91e-05	0.000862	CcSEcCtD
Procarbazine—Paraesthesia—Gemcitabine—pancreatic cancer	6.88e-05	0.000859	CcSEcCtD
Procarbazine—Chills—Docetaxel—pancreatic cancer	6.87e-05	0.000857	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	6.87e-05	0.000857	CcSEcCtD
Procarbazine—Asthenia—Sunitinib—pancreatic cancer	6.86e-05	0.000855	CcSEcCtD
Procarbazine—Decreased appetite—Irinotecan—pancreatic cancer	6.84e-05	0.000853	CcSEcCtD
Procarbazine—Arrhythmia—Docetaxel—pancreatic cancer	6.84e-05	0.000853	CcSEcCtD
Procarbazine—Insomnia—Fluorouracil—pancreatic cancer	6.82e-05	0.00085	CcSEcCtD
Procarbazine—Somnolence—Gemcitabine—pancreatic cancer	6.82e-05	0.00085	CcSEcCtD
Procarbazine—Fatigue—Irinotecan—pancreatic cancer	6.79e-05	0.000846	CcSEcCtD
Procarbazine—Paraesthesia—Fluorouracil—pancreatic cancer	6.77e-05	0.000844	CcSEcCtD
Procarbazine—Alopecia—Docetaxel—pancreatic cancer	6.77e-05	0.000844	CcSEcCtD
Procarbazine—Pruritus—Sunitinib—pancreatic cancer	6.76e-05	0.000843	CcSEcCtD
Procarbazine—Pain—Irinotecan—pancreatic cancer	6.73e-05	0.000839	CcSEcCtD
Procarbazine—Constipation—Irinotecan—pancreatic cancer	6.73e-05	0.000839	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	6.72e-05	0.000839	CcSEcCtD
Procarbazine—Somnolence—Fluorouracil—pancreatic cancer	6.7e-05	0.000836	CcSEcCtD
Procarbazine—Decreased appetite—Gemcitabine—pancreatic cancer	6.66e-05	0.000831	CcSEcCtD
Procarbazine—Nausea—Tamoxifen—pancreatic cancer	6.63e-05	0.000827	CcSEcCtD
Procarbazine—Fatigue—Gemcitabine—pancreatic cancer	6.61e-05	0.000824	CcSEcCtD
Procarbazine—Pain—Gemcitabine—pancreatic cancer	6.56e-05	0.000818	CcSEcCtD
Procarbazine—Constipation—Gemcitabine—pancreatic cancer	6.56e-05	0.000818	CcSEcCtD
Procarbazine—Nausea—Erlotinib—pancreatic cancer	6.56e-05	0.000818	CcSEcCtD
Procarbazine—Decreased appetite—Fluorouracil—pancreatic cancer	6.55e-05	0.000817	CcSEcCtD
Procarbazine—Diarrhoea—Sunitinib—pancreatic cancer	6.54e-05	0.000815	CcSEcCtD
Procarbazine—Ataxia—Doxorubicin—pancreatic cancer	6.5e-05	0.00081	CcSEcCtD
Procarbazine—Feeling abnormal—Irinotecan—pancreatic cancer	6.49e-05	0.000809	CcSEcCtD
Procarbazine—Dysphagia—Epirubicin—pancreatic cancer	6.45e-05	0.000805	CcSEcCtD
Procarbazine—Pain—Fluorouracil—pancreatic cancer	6.45e-05	0.000804	CcSEcCtD
Procarbazine—Gastrointestinal pain—Irinotecan—pancreatic cancer	6.44e-05	0.000803	CcSEcCtD
Procarbazine—Eosinophilia—Epirubicin—pancreatic cancer	6.39e-05	0.000797	CcSEcCtD
Procarbazine—Pancreatitis—Epirubicin—pancreatic cancer	6.33e-05	0.000789	CcSEcCtD
Procarbazine—Dizziness—Sunitinib—pancreatic cancer	6.32e-05	0.000788	CcSEcCtD
Procarbazine—Feeling abnormal—Gemcitabine—pancreatic cancer	6.32e-05	0.000788	CcSEcCtD
Procarbazine—Angina pectoris—Epirubicin—pancreatic cancer	6.29e-05	0.000784	CcSEcCtD
Procarbazine—Abdominal pain—Irinotecan—pancreatic cancer	6.22e-05	0.000776	CcSEcCtD
Procarbazine—Body temperature increased—Irinotecan—pancreatic cancer	6.22e-05	0.000776	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	6.22e-05	0.000776	CcSEcCtD
Procarbazine—Feeling abnormal—Fluorouracil—pancreatic cancer	6.21e-05	0.000775	CcSEcCtD
Procarbazine—Anaemia—Docetaxel—pancreatic cancer	6.16e-05	0.000769	CcSEcCtD
Procarbazine—Pancytopenia—Epirubicin—pancreatic cancer	6.13e-05	0.000764	CcSEcCtD
Procarbazine—Vomiting—Sunitinib—pancreatic cancer	6.07e-05	0.000758	CcSEcCtD
Procarbazine—Body temperature increased—Gemcitabine—pancreatic cancer	6.06e-05	0.000756	CcSEcCtD
Procarbazine—Rash—Sunitinib—pancreatic cancer	6.02e-05	0.000751	CcSEcCtD
Procarbazine—Dermatitis—Sunitinib—pancreatic cancer	6.02e-05	0.000751	CcSEcCtD
Procarbazine—Urticaria—Fluorouracil—pancreatic cancer	5.99e-05	0.000747	CcSEcCtD
Procarbazine—Headache—Sunitinib—pancreatic cancer	5.99e-05	0.000747	CcSEcCtD
Procarbazine—Syncope—Docetaxel—pancreatic cancer	5.98e-05	0.000746	CcSEcCtD
Procarbazine—Dysphagia—Doxorubicin—pancreatic cancer	5.97e-05	0.000745	CcSEcCtD
Procarbazine—Leukopenia—Docetaxel—pancreatic cancer	5.97e-05	0.000744	CcSEcCtD
Procarbazine—Pollakiuria—Epirubicin—pancreatic cancer	5.96e-05	0.000744	CcSEcCtD
Procarbazine—Body temperature increased—Fluorouracil—pancreatic cancer	5.96e-05	0.000743	CcSEcCtD
Procarbazine—Eosinophilia—Doxorubicin—pancreatic cancer	5.91e-05	0.000737	CcSEcCtD
Procarbazine—Photosensitivity reaction—Epirubicin—pancreatic cancer	5.89e-05	0.000735	CcSEcCtD
Procarbazine—Loss of consciousness—Docetaxel—pancreatic cancer	5.86e-05	0.000731	CcSEcCtD
Procarbazine—Pancreatitis—Doxorubicin—pancreatic cancer	5.85e-05	0.00073	CcSEcCtD
Procarbazine—Cough—Docetaxel—pancreatic cancer	5.82e-05	0.000726	CcSEcCtD
Procarbazine—Angina pectoris—Doxorubicin—pancreatic cancer	5.82e-05	0.000725	CcSEcCtD
Procarbazine—Hypersensitivity—Irinotecan—pancreatic cancer	5.8e-05	0.000723	CcSEcCtD
Procarbazine—Pneumonia—Epirubicin—pancreatic cancer	5.79e-05	0.000722	CcSEcCtD
Procarbazine—Convulsion—Docetaxel—pancreatic cancer	5.78e-05	0.00072	CcSEcCtD
Procarbazine—Hypertension—Docetaxel—pancreatic cancer	5.76e-05	0.000718	CcSEcCtD
Procarbazine—Drowsiness—Epirubicin—pancreatic cancer	5.75e-05	0.000718	CcSEcCtD
Procarbazine—Arthralgia—Docetaxel—pancreatic cancer	5.68e-05	0.000708	CcSEcCtD
Procarbazine—Myalgia—Docetaxel—pancreatic cancer	5.68e-05	0.000708	CcSEcCtD
Procarbazine—Nausea—Sunitinib—pancreatic cancer	5.68e-05	0.000708	CcSEcCtD
Procarbazine—Pancytopenia—Doxorubicin—pancreatic cancer	5.67e-05	0.000707	CcSEcCtD
Procarbazine—Asthenia—Irinotecan—pancreatic cancer	5.65e-05	0.000704	CcSEcCtD
Procarbazine—Neuropathy peripheral—Epirubicin—pancreatic cancer	5.64e-05	0.000703	CcSEcCtD
Procarbazine—Stomatitis—Epirubicin—pancreatic cancer	5.61e-05	0.0007	CcSEcCtD
Procarbazine—Jaundice—Epirubicin—pancreatic cancer	5.61e-05	0.0007	CcSEcCtD
Procarbazine—Hypersensitivity—Fluorouracil—pancreatic cancer	5.55e-05	0.000693	CcSEcCtD
Procarbazine—Dry mouth—Docetaxel—pancreatic cancer	5.55e-05	0.000692	CcSEcCtD
Procarbazine—Sweating—Epirubicin—pancreatic cancer	5.52e-05	0.000688	CcSEcCtD
Procarbazine—Pollakiuria—Doxorubicin—pancreatic cancer	5.52e-05	0.000688	CcSEcCtD
Procarbazine—Asthenia—Gemcitabine—pancreatic cancer	5.5e-05	0.000686	CcSEcCtD
Procarbazine—Haematuria—Epirubicin—pancreatic cancer	5.49e-05	0.000684	CcSEcCtD
Procarbazine—Confusional state—Docetaxel—pancreatic cancer	5.49e-05	0.000684	CcSEcCtD
Procarbazine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	5.45e-05	0.00068	CcSEcCtD
Procarbazine—Oedema—Docetaxel—pancreatic cancer	5.44e-05	0.000679	CcSEcCtD
Procarbazine—Epistaxis—Epirubicin—pancreatic cancer	5.43e-05	0.000677	CcSEcCtD
Procarbazine—Pruritus—Gemcitabine—pancreatic cancer	5.42e-05	0.000677	CcSEcCtD
Procarbazine—Infection—Docetaxel—pancreatic cancer	5.41e-05	0.000674	CcSEcCtD
Procarbazine—Diarrhoea—Irinotecan—pancreatic cancer	5.38e-05	0.000672	CcSEcCtD
Procarbazine—Pneumonia—Doxorubicin—pancreatic cancer	5.35e-05	0.000668	CcSEcCtD
Procarbazine—Shock—Docetaxel—pancreatic cancer	5.35e-05	0.000668	CcSEcCtD
Procarbazine—Pruritus—Fluorouracil—pancreatic cancer	5.33e-05	0.000665	CcSEcCtD
Procarbazine—Thrombocytopenia—Docetaxel—pancreatic cancer	5.33e-05	0.000664	CcSEcCtD
Procarbazine—Drowsiness—Doxorubicin—pancreatic cancer	5.32e-05	0.000664	CcSEcCtD
Procarbazine—Tachycardia—Docetaxel—pancreatic cancer	5.31e-05	0.000662	CcSEcCtD
Procarbazine—Diarrhoea—Gemcitabine—pancreatic cancer	5.25e-05	0.000654	CcSEcCtD
Procarbazine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	5.22e-05	0.000651	CcSEcCtD
Procarbazine—Dizziness—Irinotecan—pancreatic cancer	5.2e-05	0.000649	CcSEcCtD
Procarbazine—Haemoglobin—Epirubicin—pancreatic cancer	5.19e-05	0.000648	CcSEcCtD
Procarbazine—Jaundice—Doxorubicin—pancreatic cancer	5.19e-05	0.000647	CcSEcCtD
Procarbazine—Stomatitis—Doxorubicin—pancreatic cancer	5.19e-05	0.000647	CcSEcCtD
Procarbazine—Anorexia—Docetaxel—pancreatic cancer	5.19e-05	0.000647	CcSEcCtD
Procarbazine—Haemorrhage—Epirubicin—pancreatic cancer	5.17e-05	0.000644	CcSEcCtD
Procarbazine—Diarrhoea—Fluorouracil—pancreatic cancer	5.16e-05	0.000643	CcSEcCtD
Procarbazine—Sweating—Doxorubicin—pancreatic cancer	5.1e-05	0.000637	CcSEcCtD
Procarbazine—Hypotension—Docetaxel—pancreatic cancer	5.08e-05	0.000634	CcSEcCtD
Procarbazine—Haematuria—Doxorubicin—pancreatic cancer	5.08e-05	0.000633	CcSEcCtD
Procarbazine—Epistaxis—Doxorubicin—pancreatic cancer	5.02e-05	0.000626	CcSEcCtD
Procarbazine—Vomiting—Irinotecan—pancreatic cancer	5e-05	0.000624	CcSEcCtD
Procarbazine—Dizziness—Fluorouracil—pancreatic cancer	4.98e-05	0.000622	CcSEcCtD
Procarbazine—Rash—Irinotecan—pancreatic cancer	4.96e-05	0.000619	CcSEcCtD
Procarbazine—Dermatitis—Irinotecan—pancreatic cancer	4.96e-05	0.000618	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	4.96e-05	0.000618	CcSEcCtD
Procarbazine—Headache—Irinotecan—pancreatic cancer	4.93e-05	0.000615	CcSEcCtD
Procarbazine—Insomnia—Docetaxel—pancreatic cancer	4.92e-05	0.000614	CcSEcCtD
Procarbazine—Paraesthesia—Docetaxel—pancreatic cancer	4.89e-05	0.000609	CcSEcCtD
Procarbazine—Vomiting—Gemcitabine—pancreatic cancer	4.87e-05	0.000608	CcSEcCtD
Procarbazine—Somnolence—Docetaxel—pancreatic cancer	4.84e-05	0.000603	CcSEcCtD
Procarbazine—Rash—Gemcitabine—pancreatic cancer	4.83e-05	0.000603	CcSEcCtD
Procarbazine—Dermatitis—Gemcitabine—pancreatic cancer	4.83e-05	0.000602	CcSEcCtD
Procarbazine—Haemoglobin—Doxorubicin—pancreatic cancer	4.8e-05	0.000599	CcSEcCtD
Procarbazine—Headache—Gemcitabine—pancreatic cancer	4.8e-05	0.000599	CcSEcCtD
Procarbazine—Flushing—Epirubicin—pancreatic cancer	4.79e-05	0.000598	CcSEcCtD
Procarbazine—Vomiting—Fluorouracil—pancreatic cancer	4.79e-05	0.000598	CcSEcCtD
Procarbazine—Haemorrhage—Doxorubicin—pancreatic cancer	4.78e-05	0.000596	CcSEcCtD
Procarbazine—Rash—Fluorouracil—pancreatic cancer	4.75e-05	0.000593	CcSEcCtD
Procarbazine—Dermatitis—Fluorouracil—pancreatic cancer	4.75e-05	0.000592	CcSEcCtD
Procarbazine—Decreased appetite—Docetaxel—pancreatic cancer	4.73e-05	0.00059	CcSEcCtD
Procarbazine—Headache—Fluorouracil—pancreatic cancer	4.72e-05	0.000589	CcSEcCtD
Procarbazine—Fatigue—Docetaxel—pancreatic cancer	4.69e-05	0.000585	CcSEcCtD
Procarbazine—Nausea—Irinotecan—pancreatic cancer	4.67e-05	0.000583	CcSEcCtD
Procarbazine—Pain—Docetaxel—pancreatic cancer	4.65e-05	0.00058	CcSEcCtD
Procarbazine—Constipation—Docetaxel—pancreatic cancer	4.65e-05	0.00058	CcSEcCtD
Procarbazine—Chills—Epirubicin—pancreatic cancer	4.63e-05	0.000578	CcSEcCtD
Procarbazine—Arrhythmia—Epirubicin—pancreatic cancer	4.61e-05	0.000576	CcSEcCtD
Procarbazine—Alopecia—Epirubicin—pancreatic cancer	4.56e-05	0.000569	CcSEcCtD
Procarbazine—Nausea—Gemcitabine—pancreatic cancer	4.55e-05	0.000568	CcSEcCtD
Procarbazine—Feeling abnormal—Docetaxel—pancreatic cancer	4.48e-05	0.000559	CcSEcCtD
Procarbazine—Nausea—Fluorouracil—pancreatic cancer	4.48e-05	0.000558	CcSEcCtD
Procarbazine—Gastrointestinal pain—Docetaxel—pancreatic cancer	4.45e-05	0.000555	CcSEcCtD
Procarbazine—Flushing—Doxorubicin—pancreatic cancer	4.44e-05	0.000553	CcSEcCtD
Procarbazine—Tension—Epirubicin—pancreatic cancer	4.41e-05	0.00055	CcSEcCtD
Procarbazine—Nervousness—Epirubicin—pancreatic cancer	4.37e-05	0.000545	CcSEcCtD
Procarbazine—Body temperature increased—Docetaxel—pancreatic cancer	4.3e-05	0.000536	CcSEcCtD
Procarbazine—Abdominal pain—Docetaxel—pancreatic cancer	4.3e-05	0.000536	CcSEcCtD
Procarbazine—Chills—Doxorubicin—pancreatic cancer	4.29e-05	0.000535	CcSEcCtD
Procarbazine—Arrhythmia—Doxorubicin—pancreatic cancer	4.27e-05	0.000533	CcSEcCtD
Procarbazine—Alopecia—Doxorubicin—pancreatic cancer	4.22e-05	0.000527	CcSEcCtD
Procarbazine—Anaemia—Epirubicin—pancreatic cancer	4.16e-05	0.000518	CcSEcCtD
Procarbazine—Tension—Doxorubicin—pancreatic cancer	4.08e-05	0.000509	CcSEcCtD
Procarbazine—Nervousness—Doxorubicin—pancreatic cancer	4.04e-05	0.000504	CcSEcCtD
Procarbazine—Syncope—Epirubicin—pancreatic cancer	4.03e-05	0.000503	CcSEcCtD
Procarbazine—Leukopenia—Epirubicin—pancreatic cancer	4.02e-05	0.000502	CcSEcCtD
Procarbazine—Hypersensitivity—Docetaxel—pancreatic cancer	4.01e-05	0.0005	CcSEcCtD
Procarbazine—Loss of consciousness—Epirubicin—pancreatic cancer	3.95e-05	0.000493	CcSEcCtD
Procarbazine—Cough—Epirubicin—pancreatic cancer	3.92e-05	0.000489	CcSEcCtD
Procarbazine—Asthenia—Docetaxel—pancreatic cancer	3.9e-05	0.000487	CcSEcCtD
Procarbazine—Convulsion—Epirubicin—pancreatic cancer	3.9e-05	0.000486	CcSEcCtD
Procarbazine—Hypertension—Epirubicin—pancreatic cancer	3.88e-05	0.000484	CcSEcCtD
Procarbazine—Pruritus—Docetaxel—pancreatic cancer	3.85e-05	0.00048	CcSEcCtD
Procarbazine—Anaemia—Doxorubicin—pancreatic cancer	3.85e-05	0.00048	CcSEcCtD
Procarbazine—Myalgia—Epirubicin—pancreatic cancer	3.83e-05	0.000477	CcSEcCtD
Procarbazine—Arthralgia—Epirubicin—pancreatic cancer	3.83e-05	0.000477	CcSEcCtD
Procarbazine—Anxiety—Epirubicin—pancreatic cancer	3.81e-05	0.000476	CcSEcCtD
Procarbazine—Dry mouth—Epirubicin—pancreatic cancer	3.74e-05	0.000467	CcSEcCtD
Procarbazine—Syncope—Doxorubicin—pancreatic cancer	3.73e-05	0.000465	CcSEcCtD
Procarbazine—Leukopenia—Doxorubicin—pancreatic cancer	3.72e-05	0.000465	CcSEcCtD
Procarbazine—Diarrhoea—Docetaxel—pancreatic cancer	3.72e-05	0.000464	CcSEcCtD
Procarbazine—Confusional state—Epirubicin—pancreatic cancer	3.7e-05	0.000462	CcSEcCtD
Procarbazine—Oedema—Epirubicin—pancreatic cancer	3.67e-05	0.000458	CcSEcCtD
Procarbazine—Loss of consciousness—Doxorubicin—pancreatic cancer	3.66e-05	0.000456	CcSEcCtD
Procarbazine—Infection—Epirubicin—pancreatic cancer	3.65e-05	0.000455	CcSEcCtD
Procarbazine—Cough—Doxorubicin—pancreatic cancer	3.63e-05	0.000453	CcSEcCtD
Procarbazine—Shock—Epirubicin—pancreatic cancer	3.61e-05	0.00045	CcSEcCtD
Procarbazine—Convulsion—Doxorubicin—pancreatic cancer	3.6e-05	0.00045	CcSEcCtD
Procarbazine—Dizziness—Docetaxel—pancreatic cancer	3.6e-05	0.000449	CcSEcCtD
Procarbazine—Thrombocytopenia—Epirubicin—pancreatic cancer	3.59e-05	0.000448	CcSEcCtD
Procarbazine—Hypertension—Doxorubicin—pancreatic cancer	3.59e-05	0.000448	CcSEcCtD
Procarbazine—Tachycardia—Epirubicin—pancreatic cancer	3.58e-05	0.000447	CcSEcCtD
Procarbazine—Hyperhidrosis—Epirubicin—pancreatic cancer	3.55e-05	0.000442	CcSEcCtD
Procarbazine—Arthralgia—Doxorubicin—pancreatic cancer	3.54e-05	0.000442	CcSEcCtD
Procarbazine—Myalgia—Doxorubicin—pancreatic cancer	3.54e-05	0.000442	CcSEcCtD
Procarbazine—Anxiety—Doxorubicin—pancreatic cancer	3.53e-05	0.00044	CcSEcCtD
Procarbazine—Anorexia—Epirubicin—pancreatic cancer	3.5e-05	0.000436	CcSEcCtD
Procarbazine—Dry mouth—Doxorubicin—pancreatic cancer	3.46e-05	0.000432	CcSEcCtD
Procarbazine—Vomiting—Docetaxel—pancreatic cancer	3.46e-05	0.000431	CcSEcCtD
Procarbazine—Rash—Docetaxel—pancreatic cancer	3.43e-05	0.000428	CcSEcCtD
Procarbazine—Hypotension—Epirubicin—pancreatic cancer	3.43e-05	0.000428	CcSEcCtD
Procarbazine—Dermatitis—Docetaxel—pancreatic cancer	3.43e-05	0.000427	CcSEcCtD
Procarbazine—Confusional state—Doxorubicin—pancreatic cancer	3.42e-05	0.000427	CcSEcCtD
Procarbazine—Headache—Docetaxel—pancreatic cancer	3.41e-05	0.000425	CcSEcCtD
Procarbazine—Oedema—Doxorubicin—pancreatic cancer	3.4e-05	0.000424	CcSEcCtD
Procarbazine—Infection—Doxorubicin—pancreatic cancer	3.37e-05	0.000421	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	3.34e-05	0.000417	CcSEcCtD
Procarbazine—Shock—Doxorubicin—pancreatic cancer	3.34e-05	0.000417	CcSEcCtD
Procarbazine—Thrombocytopenia—Doxorubicin—pancreatic cancer	3.32e-05	0.000415	CcSEcCtD
Procarbazine—Insomnia—Epirubicin—pancreatic cancer	3.32e-05	0.000414	CcSEcCtD
Procarbazine—Tachycardia—Doxorubicin—pancreatic cancer	3.31e-05	0.000413	CcSEcCtD
Procarbazine—Paraesthesia—Epirubicin—pancreatic cancer	3.3e-05	0.000411	CcSEcCtD
Procarbazine—Hyperhidrosis—Doxorubicin—pancreatic cancer	3.28e-05	0.000409	CcSEcCtD
Procarbazine—Somnolence—Epirubicin—pancreatic cancer	3.26e-05	0.000407	CcSEcCtD
Procarbazine—Anorexia—Doxorubicin—pancreatic cancer	3.24e-05	0.000404	CcSEcCtD
Procarbazine—Nausea—Docetaxel—pancreatic cancer	3.23e-05	0.000403	CcSEcCtD
Procarbazine—Decreased appetite—Epirubicin—pancreatic cancer	3.19e-05	0.000398	CcSEcCtD
Procarbazine—Hypotension—Doxorubicin—pancreatic cancer	3.17e-05	0.000396	CcSEcCtD
Procarbazine—Fatigue—Epirubicin—pancreatic cancer	3.16e-05	0.000395	CcSEcCtD
Procarbazine—Constipation—Epirubicin—pancreatic cancer	3.14e-05	0.000391	CcSEcCtD
Procarbazine—Pain—Epirubicin—pancreatic cancer	3.14e-05	0.000391	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	3.09e-05	0.000386	CcSEcCtD
Procarbazine—Insomnia—Doxorubicin—pancreatic cancer	3.07e-05	0.000383	CcSEcCtD
Procarbazine—Paraesthesia—Doxorubicin—pancreatic cancer	3.05e-05	0.00038	CcSEcCtD
Procarbazine—Feeling abnormal—Epirubicin—pancreatic cancer	3.02e-05	0.000377	CcSEcCtD
Procarbazine—Somnolence—Doxorubicin—pancreatic cancer	3.02e-05	0.000377	CcSEcCtD
Procarbazine—Gastrointestinal pain—Epirubicin—pancreatic cancer	3e-05	0.000374	CcSEcCtD
Procarbazine—Decreased appetite—Doxorubicin—pancreatic cancer	2.95e-05	0.000368	CcSEcCtD
Procarbazine—Fatigue—Doxorubicin—pancreatic cancer	2.93e-05	0.000365	CcSEcCtD
Procarbazine—Urticaria—Epirubicin—pancreatic cancer	2.92e-05	0.000364	CcSEcCtD
Procarbazine—Constipation—Doxorubicin—pancreatic cancer	2.9e-05	0.000362	CcSEcCtD
Procarbazine—Pain—Doxorubicin—pancreatic cancer	2.9e-05	0.000362	CcSEcCtD
Procarbazine—Body temperature increased—Epirubicin—pancreatic cancer	2.9e-05	0.000362	CcSEcCtD
Procarbazine—Abdominal pain—Epirubicin—pancreatic cancer	2.9e-05	0.000362	CcSEcCtD
Procarbazine—Feeling abnormal—Doxorubicin—pancreatic cancer	2.8e-05	0.000349	CcSEcCtD
Procarbazine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	2.78e-05	0.000346	CcSEcCtD
Procarbazine—Hypersensitivity—Epirubicin—pancreatic cancer	2.7e-05	0.000337	CcSEcCtD
Procarbazine—Urticaria—Doxorubicin—pancreatic cancer	2.7e-05	0.000336	CcSEcCtD
Procarbazine—Abdominal pain—Doxorubicin—pancreatic cancer	2.68e-05	0.000335	CcSEcCtD
Procarbazine—Body temperature increased—Doxorubicin—pancreatic cancer	2.68e-05	0.000335	CcSEcCtD
Procarbazine—Asthenia—Epirubicin—pancreatic cancer	2.63e-05	0.000328	CcSEcCtD
Procarbazine—Pruritus—Epirubicin—pancreatic cancer	2.6e-05	0.000324	CcSEcCtD
Procarbazine—Diarrhoea—Epirubicin—pancreatic cancer	2.51e-05	0.000313	CcSEcCtD
Procarbazine—Hypersensitivity—Doxorubicin—pancreatic cancer	2.5e-05	0.000312	CcSEcCtD
Procarbazine—Asthenia—Doxorubicin—pancreatic cancer	2.44e-05	0.000304	CcSEcCtD
Procarbazine—Dizziness—Epirubicin—pancreatic cancer	2.43e-05	0.000303	CcSEcCtD
Procarbazine—Pruritus—Doxorubicin—pancreatic cancer	2.4e-05	0.0003	CcSEcCtD
Procarbazine—Vomiting—Epirubicin—pancreatic cancer	2.33e-05	0.000291	CcSEcCtD
Procarbazine—Diarrhoea—Doxorubicin—pancreatic cancer	2.32e-05	0.00029	CcSEcCtD
Procarbazine—Rash—Epirubicin—pancreatic cancer	2.31e-05	0.000289	CcSEcCtD
Procarbazine—Dermatitis—Epirubicin—pancreatic cancer	2.31e-05	0.000288	CcSEcCtD
Procarbazine—Headache—Epirubicin—pancreatic cancer	2.3e-05	0.000287	CcSEcCtD
Procarbazine—Dizziness—Doxorubicin—pancreatic cancer	2.25e-05	0.00028	CcSEcCtD
Procarbazine—Nausea—Epirubicin—pancreatic cancer	2.18e-05	0.000272	CcSEcCtD
Procarbazine—Vomiting—Doxorubicin—pancreatic cancer	2.16e-05	0.000269	CcSEcCtD
Procarbazine—Rash—Doxorubicin—pancreatic cancer	2.14e-05	0.000267	CcSEcCtD
Procarbazine—Dermatitis—Doxorubicin—pancreatic cancer	2.14e-05	0.000267	CcSEcCtD
Procarbazine—Headache—Doxorubicin—pancreatic cancer	2.13e-05	0.000265	CcSEcCtD
Procarbazine—Nausea—Doxorubicin—pancreatic cancer	2.02e-05	0.000252	CcSEcCtD
